Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA
Abstract Hyperuricemia is associated with an increased risk of gout, hypertension, diabetes, and cardiovascular diseases. Most mammals maintain normal serum uric acid (SUA) via urate oxidase (Uox), an enzyme that metabolizes poorly-soluble UA to highly-soluble allantoin. In contrast, Uox became a ps...
| Published in: | Nature Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-07-01
|
| Online Access: | https://doi.org/10.1038/s41467-024-50752-9 |
